Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Microsoft (NASDAQ:MSFT – Get Free Report)‘s stock had its “outperform” rating reaffirmed by investment analysts at Wedbush in ...

Immunome (NASDAQ:IMNM – Get Free Report) had its price target dropped by stock analysts at Guggenheim from $35.00 to $25.00 ...

Tesla shares surged in recent trading Friday, but were still set to lose ground for the ninth consecutive week.

Wedbush analyst Dan Ives previously warned Tesla was spiraling into a "brand crisis tornado" amid widespread protests and a ...

Wedbush analyst Robert Driscoll maintained a Buy rating on Monte Rosa Therapeutics (GLUE – Research Report) today and set a price target of ...

Leaders lead in times of trouble and crisis… and last night Elon Musk took a major and much needed step forward by hosting a rare all-hands ...

The White House is going to bat for Tesla as Elon Musk’s electric vehicle (EV) company suffers from financial woes and faces ...

Within the Magnificent Seven, one stock stands out among the pack: electric vehicle (EV) manufacturer Tesla ( TSLA 5.33%). With shares down 44% in 2025 as of Tuesday's market close, Tesla is fighting ...

Analysts lower price forecast for Williams-Sonoma after strong Q4 results, with revenue up 8% YoY and EPS beating expectations.

Wedbush’s Dan Ives says CEO Elon Musk faces a “moment of truth,” and there two major things he has to do to fix the “crisis’ ...

Long-time Tesla bull Dan Ives, an analyst at Wedbush Securities, says Elon Musk is the only one who can turn the EV maker's ...